Evogene Ltd. (EVGN) has released an update.
Evogene Ltd., a leading computational biology company, has received a notification from Nasdaq indicating non-compliance with the minimum bid price rule, as its shares closed below $1.00 for 30 consecutive days. The company has 180 days, until September 16, 2024, to meet the requirement of a $1.00 minimum bid price for ten consecutive business days to maintain its listing. Evogene remains committed to ensuring its continued listing on Nasdaq and is exploring options, including a potential reverse share split, to address the deficiency within the given timeframe.
For further insights into EVGN stock, check out TipRanks’ Stock Analysis page.
